Strategy BuilderNew COT Data Advanced News

Economic Calendar

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookiesPrivacy Policy

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
BLS
COT
Economic Calendar

Learn

Insights
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
WhatsApp

All systems operational

News Events

Track the evolution of major financial and economic events

All Breaking Developing Ongoing Fading Resolved

All Central Banks Forex Commodities Stocks Crypto Macro Geopolitics

Resolved·14 days ago

US Commerce Dept Approves Broad Rollout of OpenAI's GPT-5.6

The U.S. Department of Commerce approved the broad rollout of OpenAI's advanced GPT-5.6 model on July 8. Subsequently, OpenAI unveiled ChatGPT Work, an AI agent capable of executing tasks across multiple applications and files. Following the departure of product and business chief Fidji Simo due to chronic illness, OpenAI President Greg Brockman has taken over oversight of the company's products.

7 articles5 stories

PreviousPage 7Next

Resolved·14 days ago

ResMed Divests MatrixCare to Frazier Healthcare in Strategic Shift

ResMed has entered into a definitive agreement to sell its MatrixCare software business to Frazier Healthcare Partners for $490 million. This strategic divestment is intended to sharpen the company's focus on its core sleep health business. MatrixCare contributed approximately $220 million in revenue and $55 million in non-GAAP operating profit for fiscal year 2026.

11 articles3 stories

Resolved·14 days ago

Citi Strategist Names P&G a Top Pick Ahead of Quarterly Earnings

Citi strategist Scott Chronert identified Procter & Gamble and Progressive as top stock picks ahead of their quarterly earnings reports. Markets are currently preparing for a series of major corporate earnings releases scheduled before the opening bells on Thursday and Friday. These upcoming reports follow financial disclosures made by other companies after the market close on Thursday.

4 articles3 stories

Resolved·14 days ago

GeneDx Faces Securities Fraud Lawsuit Following 49% Stock Wipeout

A class action lawsuit was filed against GeneDx Holdings on July 7, alleging misrepresentations regarding acquisition performance. The company's stock experienced a 49% decline during the period from April 2025 to May 2026. The lawsuit was filed by Bronstein, Gewirtz & Grossman, LLC, accusing the company of violating federal securities laws. The deadline for investors to apply for lead plaintiff status is August 3, 2026.

4 articles3 stories

Resolved·14 days ago

Meta Launches Muse Image Model to Boost Generative AI Capabilities

Meta launched its Muse Image generation model through its Superintelligence Labs, followed by the release of Muse Spark 1.1 and a developer preview. The company aims to compete directly with OpenAI and Anthropic by charging for the use of its AI models. To support these capabilities, Meta announced plans to build a 1-gigawatt data center in Sturgeon County, Alberta, marking its first such facility in Canada.

15 articles4 stories

Fading·14 days ago

First Solar Gains Analyst Optimism Amid Legal Hurdles and Trade Shifts

First Solar experienced analyst optimism with upgraded ratings and price targets from Deutsche Bank and Wells Fargo, despite facing a securities fraud lawsuit. Concurrently, Element Solutions agreed to be acquired by Solstice Advanced Materials in a cash-and-stock deal valued at $14.5 billion. The combined entity projects 2025 net sales of approximately $6.8 billion, while multiple law firms are investigating the deal for potential undervaluation of Element Solutions for its shareholders.

4 articles3 stories

Fading·14 days ago

Wynn Resorts Doubles Down on Integrated Resort Strategy in Las Vegas and Macau

Wynn Resorts is currently focusing on its integrated resort strategy in Las Vegas and Macau to capitalize on the tourism recovery. Meanwhile, MGM Resorts is in negotiations for a potential deal with Barry Diller's People Inc. Additionally, the Wynn Al Marjan Island integrated resort in Ras Al Khaimah, UAE, is scheduled to open in 2027.

7 articles3 stories

Fading·14 days ago

Meitav Investment House Boosts Stake in Vistra Corp Amid Institutional Optimism

Meitav Investment House increased its stake in Vistra Corp by purchasing 200,000 additional shares in Q1 2026, while Kestra Advisory Services boosted its holding by 132.7% to a value of $13.85 million. On the operational side, Vistra Corp expanded its accounts receivable securitization facility commitment from $1.1 billion to $1.25 billion. Additionally, the company extended its funding terms and Master Framework Agreement for its repurchase facility through July 9, 2027.

4 articles3 stories

Fading·14 days ago

Oracle Cloud Revenue May Surpass 2027 Estimates, Piper Sandler Says

Piper Sandler suggests Oracle's cloud revenue could exceed fiscal year 2027 estimates, driven by significant investments in AI data centers for major customers like OpenAI. The company maintains a substantial cloud backlog that provides multi-year revenue visibility. Furthermore, Oracle's Multicloud AI Database business grew 404% year-over-year in Q4 fiscal 2026, marking it as the company's fastest-growing segment ever.

3 articles3 stories

Resolved·14 days ago

Wells Fargo Eyes Earnings Beat as Analysts Signal Growth Potential

Expectations suggest a likely earnings beat for Wells Fargo in its upcoming financial report. Analysts anticipate the stabilization of the Net Interest Margin while the company maintains its annual Net Interest Income guidance at $50 billion. Wells Fargo is scheduled to report its second-quarter 2026 earnings results on July 14 before the market opens.

6 articles3 stories

Ongoing·14 days ago

NBT Bank Increases Walmart Stake by 10% Following Strong Earnings

NBT Bank increased its stake in Walmart by 10% to 127,379 shares valued at $15.8 million, while Commonwealth Financial Services nearly doubled its holdings following Walmart's 7.4% year-over-year revenue growth. Conversely, Cullinan Associates reduced its position by 72.7%, and key insiders, including CEO Doug McMillon, sold significant amounts of stock. Walmart's market capitalization reached $906.43 billion supported by stronger-than-expected revenue results and earnings that met analyst estimates.

4 articles3 stories

Resolved·14 days ago

Generac Stock Plummets 9.5% Amid Industrial Sector Selloff

Generac Holdings stock fell 9.5% to $233.19 on Tuesday due to a broad selloff in the specialty industrial machinery sector, not due to company-specific news. Graphic Packaging Holding stock dropped 5.5% to $9.94 amid concerns over demand and input costs. Builders FirstSource shares plunged 5.7% to $73.97 due to broad weakness in the building products sector.

7 articles3 stories

Fading·14 days ago

Fastenal Faces Pressure Ahead of Q2 Earnings Amid Valuation and Margin Concerns

Fastenal faces pressure ahead of its Q2 2026 earnings report on July 13, amid analyst concerns over valuation and margin headwinds. Analysts project a 12.7% increase in EPS to $0.33 and a 12.5% rise in revenue to $2.34 billion. While some firms maintained a neutral stance due to overvaluation risks, the company saw a 14.8% boost in daily sales during May driven by strong manufacturing and construction demand. Price targets for the stock currently range between $46 and $55.

12 articles4 stories

Resolved·14 days ago

UBS Raises Fifth Third Bancorp Price Target to $65 on Positive Outlook

UBS raised its price target for Fifth Third Bancorp from $60 to $65 while maintaining a Buy rating. This follows reports that the bank significantly increased its holdings in major companies like Walmart and Mastercard during the first quarter. Specifically, the bank's stake in Walmart rose by 55.2% to $462.6 million, while its ownership in Mastercard grew by 25.7% to a total value of $435.5 million.

11 articles2 stories

Ongoing·14 days ago

IBM Shares Climb as BofA Hikes Price Target on Software Growth Optimism

BofA Securities raised its price target for IBM to $330, fueled by optimism over Confluent software revenue growth ahead of the Q2 earnings report on July 22, 2026. The company released preliminary financial results on July 14, entering the earnings period with strong momentum in AI and cloud sectors. Despite this growth, IBM faces pressure from a premium valuation and investor concerns regarding profit margins.

5 articles4 stories

Resolved·14 days ago

Hodges Capital Boosts Philip Morris Stake by 576% Following Strong Q1 Results

Hodges Capital Management increased its stake in Philip Morris by 575.9% during the first quarter, following the company's strong Q1 results which included $1.96 earnings per share and $10.15 billion in revenue. Additionally, Fifth Third Bancorp raised its holdings in Philip Morris by 70.3%, acquiring an additional 401,858 shares. During the same period, the institution also grew its stake in Amgen by 57.2%, bringing its total investment value in the company to $162.3 million.

22 articles2 stories

Fading·15 days ago

Bristol Myers Squibb's Krazati Fails Confirmatory Trial in Colorectal Cancer

Bristol Myers Squibb's Krazati, in combination with cetuximab, failed to significantly improve survival rates in metastatic colorectal cancer patients compared to chemotherapy. Meanwhile, the European Medicines Agency has initiated a rolling review of Revolution Medicines' experimental treatment for pancreatic cancer. Additionally, HitGen announced that its partner BioAge Labs has commenced a Phase 2 clinical trial for BGE-102, an oral inhibitor targeting cardiovascular risk.

6 articles4 stories

Resolved·15 days ago

Microbot Medical Reports Record 100% Growth in Q2 2026

Microbot Medical reported over 100% growth in revenue and new customers for Q2 2026, announcing plans to expand its U.S. sales territories and enter international markets. The period also saw significant M&A activity, with BiomX signing a letter of intent to acquire an Israeli security infrastructure firm, and Stereotaxis completing its acquisition of robotic innovator Robocath. Additionally, IKS Health finalized its acquisition of TruBridge, a provider of EHR and revenue cycle management solutions.

7 articles3 stories

Resolved·15 days ago

CACI Awarded $140.5 Million Ceiling Increase for U.S. Army Contract

CACI International received a contract ceiling increase exceeding $140.5 million from the U.S. Army on July 7. This was followed by the award of a six-year contract valued at up to $308 million from the U.S. Department of Veterans Affairs on July 8. Additionally, on July 13, the company secured a U.S. Department of Defense contract to deploy its SkyValor drone defense technology along the Southern Border.

3 articles3 stories

Fading·15 days ago

CCHH Enters Malaysia Data Center Market with $50M Maintenance Deal

Last week saw significant financial activity, starting on July 7 when CCHH entered the Malaysian data center market with a $50 million maintenance services agreement. On the same day, CDT Environmental Technology regained compliance with Nasdaq's minimum bid price requirement. Subsequently, on July 10, HCC Healthcare signed a business combination agreement with RF Acquisition Corp III to pursue a listing on the Nasdaq stock exchange.

3 articles3 stories

Resolved·15 days ago

Wall Street Eyes Goldman Sachs Q2 Results Amid Revenue Growth Forecasts

Goldman Sachs is scheduled to report its Q2 earnings results on July 14, 2026. Analysts expect significant growth, projecting a 32.60% increase in earnings per share to $14.47. Quarterly revenues are forecasted to reach $16.49 billion, representing a 13.10% year-over-year increase from the previous year.

12 articles4 stories

Resolved·15 days ago

Kailera Therapeutics GLP-1 Drug Hits Key Targets in Late-Stage Obesity Trials

On July 7, Kailera Therapeutics announced that its GLP-1 drug for diabetes and obesity met the primary endpoints in two late-stage trials. On the same day, the U.S. Food and Drug Administration approved Vera Therapeutics' drug to treat a potentially life-threatening kidney disease. On July 9, Dr. Reddy's Laboratories announced a delay in commercial supplies of semaglutide due to an issue with the active pharmaceutical ingredient.

6 articles4 stories

Fading·15 days ago

Semiconductor Selloff Pressures Nasdaq 100 Technical Support

Global semiconductor stocks experienced a selloff that pressured Nasdaq 100 futures, leading traders to monitor the 50-day moving average support. Despite a brief recovery in chip stocks on July 10, the NASDAQ Composite fell 0.90% by July 13, slipping below its 200-hour moving average. Concurrently, the S&P 500 remained below key resistance levels while holding near its 200-hour moving average support.

10 articles4 stories

Resolved·15 days ago

Cintas Faces Regulatory Hurdles Ahead of Q4 Earnings Release

Cintas is set to report its fiscal Q4 earnings on July 15, with analysts expecting $1.23 EPS and $2.87B in revenue. The company recently faced a regulatory delay in its merger with UniFirst following a request from the FTC. As the earnings release approaches, investor attention is focused on revenue growth, customer retention, and the operational impact of recent acquisitions.

6 articles3 stories